Lilly
Lilly’s new drug Mounjaro (tirzepatide ) wins US FDA approval
Joy Persaud
Diabetes, Lilly, Mounjaro, Type 2 diabetes
0 Comment
R&D/ Views & Analysis/ Views and analysis
Early diagnosis key to future Alzheimer’s treatments
mike.hammerton@pharmaphorum.com
Aduhelm, Alzheimer's, Alzheimer's Research UK, Biogen, Lilly, RetiSpec
0 Comment
Thumbs-down from FDA experts for Pfizer/Lilly’s painkiller tanezumab
Richard Staines
Lilly, osteoarthritis, pain, Pfizer, tanezumab
0 Comment
Market Access/ News/ News/ News/ R&D
US buys Lilly COVID antibody, as effectiveness questions remain
George Underwood
antibody, bamlanivimab, coronavirus, COVID-19, Eli Lilly, Lilly, US
0 Comment
Lilly begins trial of COVID-19 antibody treatment
George Underwood
AbCellera, coronavirus, COVID-19, Lilly
0 Comment
Lilly’s Taltz scrapes win against Humira in psoriatic arthritis
Phil Taylor
Humira, Lilly, psoriatic arthritis, Taltz
0 Comment
Lilly’s migraine drug gets key cluster headache approval
George Underwood
cluster headache, Emgality, Lilly
0 Comment
Lilly cuts $1bn deal for Centrexion’s non-opioid painkiller
Phil Taylor
Centrexion, Lilly, non-opioid painkiller
0 Comment